Innovative Medical Technologies ONWARD Medical specializes in advanced spinal cord stimulation therapies, including the CE-marked ARC-EX system, indicating a strong position in innovative neurotechnology. Opportunities exist to partner with or supply components to support their expansion into new markets, particularly in regions requiring regulatory approvals.

Growing US Presence With a strategic presence in the United States and recent launches of their ARC-EX system in the US, there is potential to target healthcare providers, hospitals, and rehabilitation centers seeking cutting-edge treatments for spinal cord injuries.

Funding and Expansion Receiving significant funding rounds, including EUR 50 million and over $2.5 million in grants, indicates strong financial backing and growth potential. This opens avenues for offering complementary medical devices, integration services, or logistical support to accelerate product commercialization.

Research and Partnerships Collaborations with academic institutions like EPFL and Lausanne University Hospital highlight a focus on R&D, creating opportunities to provide research tools, clinical trial services, or consulting to support their neuroscience initiatives.

Market and Regulatory Opportunities The recent CE Mark certification and active participation in industry events suggest a focus on compliance and market entry. Companies that support regulatory processes, clinical validation, or post-market surveillance can find sales prospects within this expanding neurotechnology ecosystem.